FTRE

Fortrea Holdings Inc

20.52

Oct 07 • 10:09 AM ET -0.26 (-1.27%)

Healthcare Biotechnology USA Small NASD

Peers: ICLR MEDP IQV CRL SHC DGX LH A DHR TMO

| Held by: IJR VTI IWM VXF VB IWN SPSM XSMO IJS FNDA

Index	RUT
Market Cap	1.95B
Enterprise Value	2.90B
Income	-85.20M
Sales	2.68B
Book/sh	5.51
Cash/sh	1.77
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14300
IPO	Jun 16, 2023

P/E	-
Forward P/E	19.05
PEG	0.42
P/S	0.73
P/B	3.72
P/C	11.57
P/FCF	9.95
EV/EBITDA	27.83
EV/Sales	1.08
Quick Ratio	0.96
Current Ratio	0.96
Debt/Eq	2.13
LT Debt/Eq	2.08
Option/Short	Yes / Yes

EPS (ttm)	-0.92
EPS next Y	1.08
EPS next Q	0.22
EPS this Y	96.38%
EPS next Y	27.55%
EPS next 5Y	45.27%
EPS past 3/5Y	- -21.68%
Sales past 3/5Y	-4.19% 1.09%
EPS Y/Y TTM	91.98%
Sales Y/Y TTM	-2.09%
EPS Q/Q	96.64%
Sales Q/Q	-4.52%
Earnings	Jul 29 BMO
EPS/Sales Surpr.	27.49% 4.73%

Insider Own	1.00%
Insider Trans	-20.56%
Inst Own	105.96%
Inst Trans	0.39%
ROA	-3.07%
ROE	-15.30%
ROIC	-5.27%
Gross Margin	16.38%
Oper. Margin	0.97%
Profit Margin	-3.18%
SMA20	4.41%
SMA50	8.71%
SMA200	34.52%
Trades

Shs Outstand	95.10M
Shs Float	94.15M
Short Float	13.33%
Short Ratio	8.67
Short Interest	12.55M
52W High	23.51 -12.74%
52W Low	8.55 139.95%
Volatility	6.65% 5.81%
ATR (14)	1.12
RSI (14)	58.26
Beta	1.91
Rel Volume	0.60
Avg Volume	1.45M
Volume	126,598

Perf Week	2.84%
Perf Month	20.26%
Perf Quarter	16.11%
Perf Half Y	113.04%
Perf YTD	18.93%
Perf Year	120.36%
Perf 3Y	-24.38%
Perf 5Y	-
Perf 10Y	-
Recom	2.43
Target Price	21.50
Prev Close	20.78
Price	20.52
Change %	-1.27%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-06-26	Upgrade	Barclays	Equal Weight → Overweight	$23
Sep-30-26	Initiated	UBS	Neutral	$22
Mar-09-26	Upgrade	TD Cowen	Hold → Buy	$15
Jan-08-26	Upgrade	Truist	Hold → Buy	$22
Jan-06-26	Upgrade	Evercore ISI	In-line → Outperform	$25
Dec-15-25	Upgrade	Barclays	Underweight → Equal Weight	$15
Dec-11-25	Upgrade	Citigroup	Neutral → Buy	$21
Aug-04-25	Upgrade	Robert W. Baird	Neutral → Outperform	$9
May-02-25	Initiated	Truist	Hold	$7
Apr-10-25	Downgrade	Barclays	Equal Weight → Underweight	$6
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$30 → $23
Dec-06-24	Downgrade	Robert W. Baird	Outperform → Neutral	$28 → $25
Sep-25-24	Downgrade	Jefferies	Buy → Hold	$25 → $21
Aug-08-24	Downgrade	Evercore ISI	Outperform → In-line	$31 → $27
Jul-24-24	Resumed	Barclays	Equal Weight	$30
Jun-06-24	Initiated	Goldman	Neutral	$28
May-29-24	Initiated	TD Cowen	Hold	$27
May-28-24	Initiated	Mizuho	Neutral	$27
Mar-22-24	Initiated	Robert W. Baird	Neutral	$43
Mar-06-24	Initiated	Deutsche Bank	Hold	$36

Show Previous Ratings

Oct-05-26 06:30AM	Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call (GlobeNewswire) +5.55%
Sep-22-26 09:00AM	CRO consolidation keeps rolling. What does that mean for pharma? (Pharma Voice)
Sep-10-26 05:08PM	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:58AM	Fortrea to Participate in September Investor Conferences (GlobeNewswire)
Sep-02-26 07:00AM	Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials (GlobeNewswire)
08:01AM	Loading…
Aug-13-26 08:01AM	This Healthcare Services Stock Has 37% Upside (Barrons.com)
Jul-29-26 03:01PM	Fortrea Holdings Inc (FTRE) Q2 2026 Earnings Call Highlights: Strong Revenue Guidance Amid ... (GuruFocus.com)
06:30AM	Fortrea Reports Second Quarter 2026 Results (GlobeNewswire)
Jul-13-26 09:00AM	Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call (GlobeNewswire)
Jun-26-26 07:00AM	Fortrea Names Jason Knoblauch as Chief Financial Officer (GlobeNewswire)
Jun-10-26 04:15PM	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-02-26 06:00PM	Fortrea to Attend Jefferies Global Healthcare Conference (GlobeNewswire)
May-05-26 12:51PM	Fortrea Holdings Inc. Q1 2026 Earnings Call Summary (Moby) +18.61%
06:00AM	Fortrea Reports First Quarter 2026 Results (GlobeNewswire)
Apr-21-26 08:45AM	Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call (GlobeNewswire)
07:00AM	Loading…
Apr-07-26 07:00AM	Fortrea Unveils Fortrea Intelligent Technology to Help Sponsors and Sites Run Smarter, More Integrated Trials (GlobeNewswire) +5.55%
Mar-10-26 04:15PM	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.95% +5.25%
Mar-03-26 10:35PM	Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Mar-02-26 10:23AM	Fortrea Holdings Inc. (FTRE) 2026 Guidance Assumes Stable FX Rates from End-2025 (Insider Monkey)
Feb-27-26 12:44PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Feb-26-26 04:12PM	Fortrea Holdings Inc (FTRE) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
03:48PM	Fortrea Q4 Earnings Call Highlights (MarketBeat)
09:55AM	Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates (Zacks)
06:24AM	Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings (StockStory)
06:00AM	Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance (GlobeNewswire)
Feb-25-26 09:49AM	Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow (StockStory)
Feb-18-26 11:03PM	3 Reasons to Sell FTRE and 1 Stock to Buy Instead (StockStory) +7.63% +5.46%
Feb-17-26 07:00AM	Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services (GlobeNewswire)
Feb-13-26 08:29PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
11:40AM	FTRE vs. PRTA: Which Stock Is the Better Value Option? (Zacks)
07:15AM	Loading…
Feb-06-26 07:15AM	Biogen Inc. (BIIB) Q4 Earnings and Revenues Top Estimates (Zacks) +6.16%
Feb-05-26 07:38PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -14.07%
Feb-02-26 09:00AM	Curreen Capital: Fortrea (FTRE) is an Example of Our "Crazy Cheap" Strategy (Insider Monkey)
Jan-29-26 08:08AM	Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call (GlobeNewswire)
Jan-28-26 11:40AM	FTRE or ACAD: Which Is the Better Value Stock Right Now? (Zacks)
Jan-16-26 04:11PM	Why Fortrea (FTRE) Stock Is Trading Up Today (StockStory)
12:13PM	Mizuho Increases Fortrea (FTRE) PT to $15 Despite Signs of Peaking Healthcare Trends (Insider Monkey)
Jan-14-26 08:55AM	Fortrea Holdings Inc. (FTRE) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jan-12-26 11:40AM	FTRE vs. ACAD: Which Stock Is the Better Value Option? (Zacks) +5.81%
Jan-09-26 11:24AM	Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-26 08:06AM	Fortrea Holdings Inc. (FTRE) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Jan-06-26 07:00AM	Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference (GlobeNewswire) +5.54%
Dec-19-25 03:16PM	Why Fortrea (FTRE) Stock Is Up Today (StockStory) +6.80%
Dec-18-25 11:50AM	Why Fortrea (FTRE) Stock Is Trading Up Today (StockStory)
Dec-11-25 07:17PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
02:16PM	Why Fortrea (FTRE) Stock Is Up Today (StockStory)
Dec-10-25 08:19PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +5.21%
06:00PM	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-04-25 07:00AM	SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery (GlobeNewswire)
Nov-25-25 01:01PM	Fortrea (FTRE) Stock Trades Up, Here Is Why (StockStory) +6.95%
07:00AM	Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences (GlobeNewswire)
Nov-24-25 06:46PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +9.63%
07:00AM	Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand (GlobeNewswire)
Nov-17-25 07:00AM	Fortrea Appoints Agnieszka Gallagher as General Counsel (GlobeNewswire) -5.96%
Nov-13-25 10:56PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -9.88%
Nov-12-25 12:36AM	5 Insightful Analyst Questions From Fortrea's Q3 Earnings Call (StockStory)
Nov-11-25 10:35PM	Q3 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory) +5.46%
10:56AM	Stock Market Today: U.S. Stocks Fall As SoftBank Disposes of Nvidia Stake, ADP Reports Job Losses (TheStreet)
Nov-06-25 05:50PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -7.78%
12:32AM	FTRE Q3 Deep Dive: Revenue Outpaces Estimates, Margin Expansion Remains a Focus (StockStory)
Nov-05-25 07:32PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +23.20%
02:55PM	Why Fortrea (FTRE) Stock Is Trading Up Today (StockStory)
02:02PM	Fortrea Holdings Inc (FTRE) Q3 2025 Earnings Call Highlights: Strong Demand and Strategic ... (GuruFocus.com)
07:40AM	Fortrea Holdings Inc. (FTRE) Q3 Earnings Lag Estimates (Zacks)
07:02AM	Fortrea (NASDAQ:FTRE) Beats Q3 Sales Expectations (StockStory)
06:30AM	Fortrea Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-03-25 10:08PM	Fortrea (FTRE) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-27-25 06:57PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -8.05%
Oct-24-25 06:43PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Oct-20-25 01:35PM	Why Fortrea (FTRE) Stock Is Trading Up Today (StockStory) +10.26%
07:00AM	Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt (GlobeNewswire)
Oct-15-25 07:00AM	Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
Oct-13-25 07:31AM	5 Value Picks to Ride Out US-China Trade Rift & Government Shutdown (Zacks)
Oct-11-25 09:48AM	Barclays Lifts Fortrea (FTRE) PT to $8 Amid Q3 2025 Life Sciences Preview (Insider Monkey)
Oct-08-25 01:45PM	Why Fortrea (FTRE) Stock Is Up Today (StockStory) +8.81%
Oct-06-25 09:41AM	Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains? (Zacks)
Oct-02-25 02:39PM	How to make money from tax-loss selling between now and the end of the year (MarketWatch)
Sep-25-25 05:10PM	Why Fortrea (FTRE) Shares Are Sliding Today (StockStory) -5.81%
Sep-22-25 04:30PM	Fortrea Appoints William Sharbaugh to Board of Directors (GlobeNewswire)
Sep-12-25 04:15PM	Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-11-25 02:15PM	Jefferies Raises Fortrea (FTRE) PT to $9.50 Amid Improved Biotech Funding (Insider Monkey)
Sep-08-25 06:57PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -11.26%
Sep-05-25 07:03PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +10.66%
Sep-03-25 12:36PM	Why Fortrea (FTRE) Stock Is Trading Up Today (StockStory) +6.79%
Aug-27-25 12:02AM	3 Reasons FTRE is Risky and 1 Stock to Buy Instead (StockStory)
Aug-25-25 09:55AM	Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit (PR Newswire) +6.30%
Aug-22-25 07:02PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +7.62%
Aug-21-25 11:37PM	Reflecting On Drug Development Inputs & Services Stocks' Q2 Earnings: Fortrea (NASDAQ:FTRE) (StockStory)
Aug-19-25 12:09AM	Jefferies Raises PT on Fortrea Holdings Inc. (FTRE); Truist Financial Maintains 'Hold' Rating (Insider Monkey)
Aug-13-25 01:37AM	5 Insightful Analyst Questions From Fortrea's Q2 Earnings Call (StockStory) +7.25%
Aug-12-25 08:00AM	Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial (PR Newswire) +14.40%
03:18AM	FTRE Q2 Deep Dive: Revenue Growth Driven by Clinical Pharmacology and Operational Restructuring (StockStory)
Aug-07-25 08:48PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +10.03% -9.12%
Aug-06-25 01:20PM	Why Fortrea (FTRE) Shares Are Sliding Today (StockStory)
07:45AM	Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates (Zacks)
07:36AM	Fortrea (NASDAQ:FTRE) Reports Bullish Q2, Stock Soars (StockStory)
06:30AM	Fortrea Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 06:00PM	Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations (GlobeNewswire)
08:15AM	AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-04-25 11:06PM	Fortrea (FTRE) Reports Earnings Tomorrow: What To Expect (StockStory) +17.58%

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

CEO & DirectorMr. Anshul Thakral

COO & President of Clinical ServicesMr. Mark A. Morais

Executive OfficerMs. Jill McConnell

President & Chief Commercial OfficerMr. Drayton Virkler

Chief Financial OfficerMr. Jason F. Knoblauch

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mcconnell Jill G.	Former Officer	Sep 11 '26	Proposed Sale	17.14	1,032	17,692		Sep 11 03:22 PM
Russell Carrie Elizabeth	Interim CAO	Sep 08 '26	Option Exercise	0.00	850	0	2,630	Sep 10 04:08 PM
Russell Carrie Elizabeth	Interim CAO	Sep 09 '26	Sale	16.85	246	4,145	2,384	Sep 10 04:08 PM
Morais Mark A.	Chief Operating Officer	Sep 08 '26	Option Exercise	0.00	7,157	0	84,943	Sep 10 04:05 PM
Morais Mark A.	Chief Operating Officer	Sep 09 '26	Sale	16.85	3,149	53,061	81,794	Sep 10 04:05 PM
Mcconnell Jill G.	Former Officer	Sep 10 '26	Proposed Sale	16.53	1,071	17,700		Sep 10 03:20 PM
Morais Mark A.	Officer	Sep 09 '26	Proposed Sale	16.85	3,149	53,049		Sep 09 03:54 PM
Mcconnell Jill G.	Former Officer	Sep 09 '26	Proposed Sale	16.85	1,051	17,706		Sep 09 03:44 PM
Russell Carrie Elizabeth	Officer	Sep 09 '26	Proposed Sale	16.85	246	4,144		Sep 09 03:43 PM
Morais Mark A.	Chief Operating Officer	Aug 18 '26	Option Exercise	0.00	11,313	0	82,678	Aug 19 06:51 PM
Morais Mark A.	Chief Operating Officer	Aug 19 '26	Sale	18.19	4,892	88,985	77,786	Aug 19 06:51 PM
Morais Mark A.	Officer	Aug 19 '26	Proposed Sale	18.19	4,892	88,975		Aug 19 03:24 PM
Mcconnell Jill G.	Officer	Aug 19 '26	Proposed Sale	18.19	4,892	88,975		Aug 19 03:21 PM
Thakral Anshul	Chief Executive Officer	Aug 06 '26	Sale	18.11	111,857	2,026,284	204,940	Aug 07 04:05 PM
Thakral Anshul	Chief Executive Officer	Aug 04 '26	Option Exercise	0.00	416,666	0	416,666	Aug 06 04:18 PM
Thakral Anshul	Chief Executive Officer	Aug 05 '26	Sale	19.16	99,869	1,913,111	316,797	Aug 06 04:18 PM
Thakral Anshul	Officer	Aug 06 '26	Proposed Sale	18.11	111,857	2,026,111		Aug 06 03:21 PM
SANDERS MACHELLE	Director	Aug 03 '26	Sale	18.01	9,700	174,697	36,399	Aug 05 04:04 PM
Thakral Anshul	Officer	Aug 05 '26	Proposed Sale	19.16	99,869	1,913,360		Aug 05 03:54 PM
SANDERS MACHELLE	Director	Aug 03 '26	Proposed Sale	18.01	9,700	174,697		Aug 03 01:22 PM
Smith David Ross	Director	Jul 20 '26	Option Exercise	0.00	6,598	0	36,715	Jul 27 07:52 AM
SANDERS MACHELLE	Director	Jun 10 '26	Option Exercise	0.00	38,817	0	46,099	Jun 12 04:18 PM
Smith David Ross	Director	Jun 10 '26	Option Exercise	0.00	38,817	0	48,361	Jun 12 04:17 PM
Pesicka Edward A	Director	Jun 10 '26	Option Exercise	0.00	38,817	0	52,453	Jun 12 04:15 PM
Morais Mark A.	Chief Operating Officer	Jun 10 '26	Sale	16.82	4,674	78,617	71,365	Jun 12 04:10 PM
Ray Amrit	Director	Jun 10 '26	Option Exercise	0.00	38,817	0	52,453	Jun 12 04:09 PM
Russell Erin L	Director	Jun 10 '26	Option Exercise	0.00	38,817	0	72,617	Jun 12 04:07 PM
Morais Mark A.	Officer	Jun 10 '26	Proposed Sale	16.82	4,674	78,640		Jun 10 02:54 PM
Morais Mark A.	Chief Operating Officer	Jun 01 '26	Option Exercise	0.00	11,006	0	80,905	Jun 03 04:08 PM
Morais Mark A.	Chief Operating Officer	Jun 02 '26	Sale	15.49	4,866	75,374	76,039	Jun 03 04:08 PM
Mcconnell Jill G.	Chief Financial Officer	Jun 01 '26	Option Exercise	0.00	11,006	0	83,282	Jun 03 04:06 PM
Mcconnell Jill G.	Chief Financial Officer	Jun 02 '26	Sale	15.49	4,866	75,374	78,416	Jun 03 04:06 PM
Mcconnell Jill G.	Officer	Jun 02 '26	Proposed Sale	15.49	4,866	75,365		Jun 02 03:27 PM
Morais Mark A.	Officer	Jun 02 '26	Proposed Sale	15.49	4,866	75,365		Jun 02 03:11 PM
Parks Robert	Chief Accounting Officer	May 18 '26	Sale	13.44	2,000	26,880	20,389	May 20 04:09 PM
NEUPERT PETER M	Director	May 14 '26	Option Exercise	0.00	148,536	0	246,668	May 18 04:34 PM
Parks Robert	Officer	May 18 '26	Proposed Sale	13.44	2,000	26,870		May 18 04:24 PM
Russell Erin L	Director	Mar 20 '26	Option Exercise	0.00	23,946	0	33,800	Mar 24 04:05 PM
Morais Mark A.	Chief Operating Officer	Mar 13 '26	Option Exercise	0.00	4,284	0	71,703	Mar 17 04:08 PM
Morais Mark A.	Chief Operating Officer	Mar 16 '26	Sale	9.22	1,804	16,633	69,899	Mar 17 04:08 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 13 '26	Option Exercise	0.00	4,284	0	74,080	Mar 17 04:06 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 16 '26	Sale	9.22	1,804	16,633	72,276	Mar 17 04:06 PM
Mcconnell Jill G.	Officer	Mar 16 '26	Proposed Sale	9.22	1,804	16,627		Mar 16 04:13 PM
Morais Mark A.	Officer	Mar 16 '26	Proposed Sale	9.22	1,804	16,627		Mar 16 04:08 PM
Parks Robert	Chief Accounting Officer	Mar 09 '26	Option Exercise	0.00	5,270	0	24,316	Mar 11 05:16 PM
Parks Robert	Chief Accounting Officer	Mar 10 '26	Sale	9.07	1,927	17,478	22,389	Mar 11 05:16 PM
Morais Mark A.	Chief Operating Officer	Mar 09 '26	Option Exercise	0.00	13,966	0	72,018	Mar 11 05:14 PM
Morais Mark A.	Chief Operating Officer	Mar 10 '26	Sale	9.07	4,599	41,713	67,419	Mar 11 05:14 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 09 '26	Option Exercise	0.00	15,283	0	74,857	Mar 11 05:10 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 10 '26	Sale	9.07	5,061	45,903	69,796	Mar 11 05:10 PM
Morais Mark A.	Officer	Mar 10 '26	Proposed Sale	9.07	4,599	41,717		Mar 10 03:31 PM
Parks Robert	Officer	Mar 10 '26	Proposed Sale	9.07	1,927	17,480		Mar 10 03:27 PM
Mcconnell Jill G.	Officer	Mar 10 '26	Proposed Sale	9.07	5,061	45,908		Mar 10 03:13 PM
Morais Mark A.	Chief Operating Officer	Feb 09 '26	Option Exercise	0.00	2,255	0	59,231	Feb 11 07:04 PM
Morais Mark A.	Chief Operating Officer	Feb 10 '26	Sale	13.88	1,179	16,365	58,052	Feb 11 07:04 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 09 '26	Option Exercise	0.00	1,685	0	60,455	Feb 11 07:02 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 10 '26	Sale	13.88	881	12,229	59,574	Feb 11 07:02 PM
Mcconnell Jill G.	Officer	Feb 10 '26	Proposed Sale	13.88	881	12,230		Feb 10 04:21 PM
Morais Mark A.	Officer	Feb 10 '26	Proposed Sale	13.88	1,179	16,367		Feb 10 04:19 PM
Hanson James S.	Former Officer	Jan 20 '26	Proposed Sale	15.57	27,736	431,935		Jan 20 03:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FTRE

Fortrea Holdings Inc

Upgrade your Finviz experience